Published: 7 March 2024
Publications
Quarterly summary of recent safety communications
Published 7 March 2024
Prescriber Update 45(1): 11
March 2024
The table below is a summary of recent safety communications for
healthcare professionals and consumers. Click on a specific topic to
go to the communication.
| Date |
Communication |
Topic |
| 04/03/2024 |
Alert |
Recent cases of lead poisoning with Ayurvedic medicines |
| 25/01/2024 |
Dear Healthcare Professional Letter |
Paxlovid (nirmatrelvir + ritonavir) – pack changes, updated
contraindications, dosing
(PDF, 7 pages, 630 KB) |
| 24/01/2024 |
Consumer leaflet |
Epilepsy medicines and pregnancy (Te Reo version) (PDF,
2 pages, 569 KB) |
| 23/01/2024 |
Media release |
Medsafe successfully prosecutes seller of fake “Miracle Cure”
|
| 15/01/2024 |
Monitoring |
DPP-4 inhibitors and the possible risk of ileus |
| 29/12/2023 |
Consumer leaflet |
New labelling requirements for excipients
(PDF, 2 pages, 157 KB) |
| 12/12/2023 |
Consumer leaflet |
Epilepsy medicines and pregnancy
(PDF, 2 pages, 271 KB) |
| 07/12/2023 |
Alert |
Update – Sodium valproate (Epilim) use in people who can father
children: important new safety information |
| 28/11/2023 |
Dear Healthcare Professional Letter |
Epilim (valproate) – Potential risk to children of fathers treated
with valproate: update
(PDF, 2 pages, 179 KB) |
| 28/11/2023 |
Committees |
Update – Reclassification of methenamine hippurate |
